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Abstract
Background: According to the gateway hypothesis, tobacco use is a gateway of cannabis use. However, there is
increasing evidence that cannabis use also predicts the progression of tobacco use (reverse gateway hypothesis).
Unfortunately, the importance of cannabis use compared to other predictors of tobacco use is less clear. The aim of
this study was to examine which variables, in addition to cannabis use, best predict the onset of daily cigarette
smoking in young men.
Methods: A total of 5,590 young Swiss men (mean age = 19.4 years, SD = 1.2) provided data on their substance
use, socio-demographic background, religion, health, social context, and personality at baseline and after
18 months. We modelled the predictors of progression to daily cigarette smoking using logistic regression analyses
(n = 4,230).
Results: In the multivariate overall model, use of cannabis remained among the strongest predictors for the onset
of daily cigarette use. Daily cigarette use was also predicted by a lifetime use of at least 50 cigarettes, occasional
cigarette use, educational level, religious affiliation, parental situation, peers with psychiatric problems, and
sociability.
Conclusions: Our results highlight the relevance of cannabis use compared to other potential predictors of the
progression of tobacco use and thereby support the reverse gateway hypothesis.
Background
Many variables could be important for the progression
of tobacco use. The identification of the relevant ones
that best predict the progression of tobacco use is highly
important because tobacco use is, by far, more wide-
spread than cannabis and other illicit drug use and
accounts for a significantly greater global burden of dis-
ease [1]. Identifying which young adults show a higher
risk of transition to more involved stages of tobacco use
would be helpful for indicative prevention efforts in this
age group.
One of the discussed predictors of tobacco use is can-
nabis use. Tobacco use can act as a gateway to cannabis
use [2], but the reverse has also been observed, i.e., can-
nabis use acting as a gateway to the initiation of tobacco
use [3, 4]. Furthermore, the probability of progressing
from occasional to regular tobacco smoking and nicotine
dependence is higher in smokers who also use cannabis
[4–6]. However, the underlying mechanisms connecting
tobacco and cannabis use are less clear but are assumed
to go beyond the mechanisms underlying the co-use of
substances such as tobacco and alcohol in general [7].
Moreover, the relative importance of the mechanisms
that contribute to the co-use of tobacco and cannabis
may vary across development [8] and stages of use [9].
The way of substance administration is probably
among the most important connecting mechanisms of
tobacco and cannabis use. In the qualitative study by
Amos and colleagues [10], many participants reported
that smoking joints, i.e., co-administration of cannabis
and tobacco, served as a gateway to smoking cigarettes.
A study by Agrawal and Lynskey [11] underlined the im-
portance of the way of administration in linking canna-
bis and tobacco use. In this study, smoking tobacco was
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significantly associated with cannabis use and dependence
whereas the use of smokeless tobacco was not. Because of
the shared route of administration, tobacco and cannabis
smoking may serve as behavioural cues for one another
and therefore reinforce one another [7]. Moreover, the
cross-drug reinforcement of tobacco and cannabis use
also occurs on a pharmacological level. Tobacco and can-
nabis affect the same neural pathways, with some systems
being mutually enhanced by the two substances and
others having contrasting effects [12]; additionally, nico-
tine may prolong and enhance the subjective effects of
cannabis [3, 13]. The co-administration of cannabis and
tobacco is the most widespread way of cannabis adminis-
tration in many countries, such as Australia [14] and
Switzerland, where 97.3 % of young cannabis using men
reported mulling, i.e., smoking cannabis as joints mixed
with tobacco [15]. In the United States, cannabis is often
wrapped in a tobacco leaf and smoked as “blunts” [16]
and the majority of cannabis users additionally smoke cig-
arettes [17]. It is therefore crucial to evaluate the import-
ance of cannabis use in predicting the initiation of
cigarette smoking or progression from occasional to regu-
lar cigarette smoking.
Apart from the way of administration, the common li-
ability model can also explain the strong association be-
tween tobacco and cannabis use. This model assumes that
a common liability to using both licit and illicit drugs puts
an individual at risk for using both legal and illegal sub-
stances, such as tobacco and cannabis. This liability may
include a genetic and individual vulnerability, such as
proneness to deviant personality and familial liability to
addiction [18]. Peer influences in adolescence appear to be
one factor that influences individual vulnerability. By ana-
lysing the origins of the correlation between tobacco, alco-
hol, and cannabis use among adolescents, an Australian
study found an individual’s vulnerability to substance use
to be an explaining factor [19]. Vulnerability, in turn, was
predicted by the extent to which the individual was affili-
ated with delinquent and substance using peers.
Other potential predictors that could influence tobacco
and/or cannabis use are religiosity and context variables
such as socio-economic status or changes in social envi-
ronments. Religious and pro-social activities are negatively
associated with late-onset cannabis use [11] whereas sub-
stantial gains or losses in religiosity from childhood to
adulthood are positively associated with substance use and
misuse in the general U.S. population [20]. A recent longi-
tudinal study suggested that individuals who experienced a
declining socio-economic position from childhood to
adulthood may be twice as likely to use tobacco and canna-
bis compared to individuals with a stable trajectory [21].
The aim of this study was to explore how the onset of
daily cigarette smoking can be best predicted from a
comprehensive set of variables, including cannabis use.
Methods
Study design and procedure
The present data are part of the Cohort Study on Sub-
stance Use Risk Factors (C-SURF), a longitudinal study
designed to assess substance use patterns and their re-
lated consequences in young Swiss men. Enrolment in
the study occurred between 2010 and 2011 in three
Swiss army recruitment centres, which cover 21 of the
26 Swiss cantons. (A canton is a type of administrative
division of a country and the Swiss cantons are semi-
sovereign states.) Switzerland has a mandatory army re-
cruitment process: virtually all young men are contacted
at approximately 19 years of age for determination of
their eligibility for military or civil service. Thus, not
only individuals who were finally selected to serve in the
army were enrolled in the study, but a virtually complete
census of the Swiss male population in this age group
was eligible. The participants filled in the questionnaire
online or via mail and were rewarded with a voucher of
30 Swiss Francs (CHF).
The follow-up assessment was conducted approxi-
mately 15 months after the baseline measurement, and
the participants were reimbursed with a similar voucher.
The participants who filled in both questionnaires re-
ceived an additional voucher (30 CHF). Between the as-
sessments, the participants were invited twice to update
their contact details online. Each of these two updates
was rewarded with a voucher (5 CHF) once the second
questionnaire was completed.
The Ethics Committee for Clinical Research of
Lausanne University Medical School approved the study
(Protocol No. 15/07).
Participants
A total of 15,074 young men visited the recruitment
centres. Among them, 1,829 (12.1 %) did not meet the
research staff because they were sick (but not chronically
ill), were randomly selected to participate in another
study [22], or were not informed about the study by the
military staff. These non-inclusions were random and
should not have influenced the findings. More informa-
tion about sampling and non-response can be found in
Studer et al. [23]. Of the 13,245 conscripts informed
about the study, 7,563 (57.1 %) provided consent for par-
ticipation, and 5,990 of those (79.2 %) completed the
baseline questionnaire. The follow-up questionnaire was
completed by 5,223 participants (87.2 %).
For the model of progression from no or occasional
cigarette use at baseline to daily cigarette use at follow-
up, we excluded 1,275 of the 5,990 individuals (21.3 %)
because of daily cigarette use already at baseline and an
additional 485 individuals (8.1 %) because of missing
data, resulting in a final sample of 4,230 individuals.
Becker et al. BMC Public Health  (2015) 15:843 Page 2 of 10
Measures
Outcome variable: onset of daily cigarette use
The participants indicating cigarette use during the previ-
ous 12 months were asked how often they usually smoke
cigarettes. The possible answers (“every day”, “5–6 days
per week”, “3–4 days per week”, “1–2 days per week”,
“2–3 days per month”, and “once per month or less”)
were dichotomised (daily vs. non-daily use). For the
analysis of the onset of daily cigarette smoking, the
sample included all the participants who used cigarettes
less than daily or not at all at baseline. Among these par-
ticipants, reporting daily cigarette smoking at follow-up
was classified as the onset of cigarette use.
Predictor variables
All the predictor variables were measured at baseline.
Socio-demographics The socio-demographic predictors
included age in years and the highest completed level of
education divided into two categories: a lower educa-
tional level (compulsory education or vocational school
training) and a higher educational level (upper secondary
education, college and university degrees). Additional
socio-demographic predictors included the housing situ-
ation (living alone, living with a parent or parents, living
with a partner, living with friends or in an institution),
the means of subsistence (own person, own person and
other persons or institutions, other persons or institu-
tions), living in a partnership (yes/no), and the number
of siblings.
Religion and religiosity Religious denomination was
assessed by the question “What is your religion (even if
you do not practice or believe in God)?” with nine re-
sponse categories, which we merged into four categories:
Christian religion, Muslim religion, other religion, and
no religion. To measure religiosity, we used the first
question of the Religious Background and Behaviour
Questionnaire (RBB) [24] with the response categories
(1) “I believe in God and practice religion”, (2) “I believe
in God but do not practice religion”, (3) “I do not know
what to believe about God”, (4) “I believe we cannot
really know about God” (agnostic), or (5) “I do not be-
lieve in God” (atheist).
Health and health behaviour Physical and mental
health were measured by the Physical Component Sum-
mary and the Mental Component Summary of the 12-Item
Short-Form Health Survey (SF-12) [25], the Major Depres-
sion Inventory (MDI) [26], and the International Physical
Activity Questionnaire (IPAQ) [27]. In a study using data
from 9 different countries, correlations of both the Mental
and the Physical Component Summary measures of the
SF-12 and the SF-36 were between .94 and .97 [28].
Various studies have shown that the SF-36 is a valid and
reliable measure of population health [28, 29]. A study of
the psychometric properties of the MDI indicated adequate
internal and external validity (high correlation of 0.86 with
the Hamilton Depression Scale) [26].
Social context The parental situation was assessed by a
question derived from the Alcohol Use Disorder and As-
sociated Disabilities Interview Schedule-IV (AUDADIS-
IV) [30]. The parents’ educational level was assessed and
categorised analogous to the educational level of the
study participant (see above). The financial situation of
the family was measured with a question from the Euro-
pean School Survey Project on Alcohol and Other Drugs
(ESPAD) [31]; this question uses a 7-point scale (“very
much below average”—“very much above average”) to
assess how well off the individual’s family is compared to
other Swiss families.
Parenting was assessed by three variables used in the
ESPAD. Two questions (“Before you were 18 years old,
how satisfied were you usually with your relationship
with (a) your mother and (b) your father?”) measured
the participants’ retrospective satisfaction with the rela-
tionship with their parents on scales ranging from 1
(“very satisfied”) to 5 (“not satisfied at all”). The scores
were dichotomised at the median of the mean of the
items assessing maternal and paternal relationships. Two
questions with response scales ranging from 1 (“almost
always”) to 5 (“almost never”) were used to derive parental
regulation at the age of 15 years: “My parents set definite
rules about what I was allowed to do (a) at home and (b)
outside the home”. The scores were averaged and dichoto-
mised at the median. The retrospective assessment of par-
ental knowledge of peers and the whereabouts at age 15
were derived by averaging and dichotomising the scores
obtained from the responses to two five-point items: “My
parents knew (a) whom I was with and (b) where I was in
the evenings.” Parental rule setting and knowledge of
peers and the whereabouts was asked at around age 15
because this is the time when peer influences become
stronger, and particularly meeting with friends without
the participation of parent increases [32]. For example,
the Study on Health Behaviour in School-Aged Chil-
dren (HBSC) across 41 European countries showed that
peer influences, such as being four or more days per
week out with friends, increase strongly between the
ages of 11 and 15 [33].
The lifetime prevalence of psychiatric, alcohol or drug
problems in the parents was assessed separately for both
parents. The participants indicated whether a significant
problem had ever been present in one or several domains
(i.e., psychiatric problem, alcohol problem, or drug prob-
lem). A similar question addressed previous significant al-
cohol, drug, or psychiatric problems in peers. Peer pressure
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was assessed by a shortened version of the Peer Pressure
Inventory (PPI) [34].
Substance use Lifetime use of alcohol was assessed by
the question “Did you have at least 12 alcoholic standard
drinks in your entire life?” Examples for alcoholic stand-
ard drinks were pictured. Furthermore, the age of the
first use of at least one standard alcoholic drink, the 12-
month prevalence, and at-risk drinking were assessed.
The possible answers (“every day”, “5–6 days per week”,
“3–4 days per week”, “1–2 days per week”, “2–3 days per
month”, “once per month or less”) were dichotomised
(daily vs. non-daily use). Participants who indicated ‘yes’
were classified by the Alcohol Use Disorders Identifica-
tion Test (AUDIT-C) [35] as not at risk (score < 4) or at
risk drinkers (score ≥ 4) [36]; participants who indicated
‘no’ were classified into the category ‘no alcohol use in
the previous 12 months’. In studies, which compared the
AUDIT-C to other, more comprehensive screening in-
struments for alcohol use disorders, the AUDIT-C
showed good sensitivity, specificity and positive predictive
validity [36, 37].
To assess the lifetime use of cigarettes, participants indi-
cated whether they consumed at least 50 cigarettes in their
life. Furthermore, the age of first cigarette smoking and
the 12-month prevalence of cigarette smoking were
assessed (see above). Additionally, the 12-month preva-
lence for the use of tobacco products other than cigarettes
(i.e., water pipes (shisha, smoked only with tobacco), snus,
snuff, chewing tobacco, cigars/cigarillos, tobacco pipes)
was measured.
The lifetime use of cannabis was assessed by asking
“Have you ever consumed cannabis (grass, hashish, mari-
huana), more than just to try?” Subsequent questions
measured the age of first cannabis use and problematic
cannabis use, which was assessed with the Cannabis Use
Disorders Identification Test (CUDIT) [38]. Although the
internal consistency of the CUDIT seems appropriate
(.72–.78), the predictive power of the instrument, tested in
different studies, is mixed [39]. A cut-off value of 8 was
used to discriminate problematic from non-problematic
cannabis use.
The lifetime use of illicit drugs other than cannabis at
baseline was assessed by a series of questions measuring
the frequency of use of 15 illicit drugs within the course
of the individual’s life (e.g., hallucinogens, speed, am-
phetamines, crystal meth, poppers, ecstasy, cocaine/
crack/freebase, and heroin). The lifetime use of illicit
drugs was defined as having used at least one of these
substances at least once.
Personality Screening for adult attention deficit syn-
drome was performed with the Attention Deficit Syn-
drome Self Report Scale (ASRS-v1.1) [40]. Sensation
seeking was measured by the Brief Sensation Seeking
Scale (BSSS-8) [41]. In two studies, the BSSS-8 showed
good internal consistencies (α = .76 and α = .74) and was
predictive of other risk and protective factors [42]. Ag-
gression/hostility, sociability and neuroticism/anxiety
were assessed by the corresponding subscales of the
Zuckerman-Kuhlman Personality Scale (ZKPQ-50-cc)
[43]. In a validation sturdy, this instrument showed good
psychometric and structural properties in four different
languages with alpha coefficients above .70 [44]. Peer
pressure was assessed by a shortened version of the Peer
Pressure Inventory (PPI), which showed acceptable test-
retest and inter-rater reliability in a study examining the
perception of peer pressure [34]. The presence of an anti-
social personality disorder (ASPD) was assessed by ques-
tions of the Mini International Neuropsychiatric Interview
[45]. It involves two sections with six childhood criteria. If
two of these criteria were positive, then the subjects were
asked about six behaviours since age 15. Three affirmative
answers qualified for ASPD.
Analyses
Starting with separate logistic regression analyses (subse-
quently termed ‘univariate analyses’), we evaluated the po-
tential of each baseline variable to predict the onset of
daily cigarette use. To reduce multicollinearity within the
final multivariate model, we developed separate multivari-
ate prediction models for each of the following categories
of predictor variables: (1) socio-demographics, (2) religion
and spirituality, (3) health and health behaviour, (4) social
context, (5) substance use, and (6) personality. Variable se-
lection comprised the following steps: (1) Significant pre-
dictors from the univariate analyses were entered into the
separate models. (2) Variables that were not significant
were removed manually one by one; variables with the
highest p-values were removed first (backward selection).
(3) To account for suppressor effects, the resulting models
were verified by tentatively adding the excluded variables
separately. Only significant variables were retained in the
category-specific multivariate models (forward selection).
Based on the results of these models, we developed one
final model for the onset of daily cigarette use. Variable se-
lection was conducted in an analogous way as described
above, with the exception of including all significant pre-
dictors from the category-specific models at step (1).
Nagelkerke’s R2 was calculated as a goodness-of-fit meas-
ure for all multivariate models. All the analyses were per-
formed using SPSS version 20 [46], and p < 0.05 was set as
the significance level.
Results
Sample characteristics
The baseline characteristics of the 4,230 participants in-
cluded in the analysis of the onset of daily cigarette
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Table 1 Baseline characteristics for individuals with and without the onset of cigarette use and univariate associations with the
onset of daily cigarette use
Variable categories and variables No onset n = 3961 Onset n = 269 OR (95 % CI) P
Socio-demographics
Age in years, M (SD) a 19.4 (1.2) 19.4 (1.2) 0.99 (0.89–1.10) .827
Lower educational level (Ref) b 2,758 (70.9 %) 220 (82.7 %)
Higher educational level 1,132 (29.1 %) 46 (17.3 %) 0.51 (0.37–0.71) <.001
Living with parent or parents (Ref) c 3,598 (91.5 %) 232 (86.6 %)
Living alone 98 (2.5 %) 10 (3.7 %) 1.58 (0.82–3.07) .175
Living with partner 87 (2.2 %) 9 (3.4 %) 1.60 (0.80–3.23) .185
Living with friends or in institution 151 (3.8 %) 17 (6.3 %) 1.75 (1.04–2.93) .035
Means of subsistence: own person (Ref) d 776 (19.7 %) 58 (21.7 %)
Own person and others persons or institutions 1,643 (41.6 %) 129 (48.3 %) 1.06 (0.77–1.46) .739
Other persons or institutions 1,522 (38.7 %) 80 (30.0 %) 0.70 (0.50–0.997) .048
Not living in a partnership (Ref) e 3,767 (95.8 %) 251 (94.0 %)
Living in a partnership 166 (4.2 %) 16 (6.0 %) 1.45 (0.85–2.45) .171
Having no siblings (Ref) f 243 (6.3 %) 20 (7.7 %)
One or two siblings 2,938 (76.6 %) 195 (75.3 %) 0.81 (0.50–1.30) .378
Three or more siblings 656 (17.1 %) 44 (17.0 %) 0.82 (0.47–1.14) .465
Religion and spirituality
Christian religion (Ref) g 2,949 (75.5 %) 176 (66.9 %)
Muslim religion 142 (3.6 %) 10 (3.8 %) 1.18 (0.61–2.28) .623
Other religion 87 (2.2 %) 6 (2.3 %) 1.16 (0.50–2.68) .736
No religion 727 (18.6 %) 71 (27.0 %) 1.64 (1.23–2.18) .001
Atheist (Ref) h 1,025 (26.3 %) 86 (32.6 %)
Agnostic 670 (17.2 %) 44 (16.7 %) 0.78 (0.54–1.14) .202
Unsure what to think about god 491 (12.6 %) 37 (14.0 %) 0.90 (0.60–1.34) .599
Believe in god but not practicing 1,201 (30.8 %) 77 (29.2 %) 0.76 (0.56–1.05) .098
Believe in god and practicing 516 (13.2 %) 20 (7.6 %) 0.46 (0.28–0.76) .002
Health and health behaviour
Physical health (SF-12, scale 0–100), M (SD) i 55.2 (5.0) 54.8 (5.2) 0.98 (0.96–1.01) .133
Mental health (SF-12, scale 0–100), M (SD) j 49.9 (8.4) 49.2 (9.0) 0.99 (0.98–1.01) .220
Depression (MDI, scale 0–50), M (SD) k 6.6 (6.7) 8.0 (8.0) 1.03 (1.01–1.04) .001
Low physical activity (IPAQ) (Ref) l 355 (9.6 %) 19 (7.8 %)
Moderate physical activity 953 (25.9 %) 60 (24.7 %) 1.18 (0.69–2.00) .548
High physical activity 2,371 (64.4 %) 164 (67.5 %) 1.29 (0.79–2.11) .303
Social context
Grew up with both parents (Ref) m 3,181 (81.2 %) 185 (70.1 %)
…with parent and step-parent 185 (4.7 %) 29 (11.0 %) 2.70 (1.77–4.10) <.001
…with one parent 500 (12.8 %) 47 (17.8 %) 1.62 (1.16–2.26) .005
…with adoptive or foster parents or in institution 51 (1.3 %) 3 (1.1 %) 1.01 (0.31–3.27) .985
No parental divorce before the age of 18 (Ref) n 3,066 (78.4 %) 183 (69.6 %)
Parental divorce before the age of 18 846 (21.6 %) 80 (30.4 %) 1.58 (1.21–2.08) .001
Lower educational level of the father (Ref) o 1,998 (51.2 %) 133 (50.6 %)
Higher educational level of the father 1,904 (48.8 %) 130 (49.4 %) 1.03 (0.80–1.32) .842
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Table 1 Baseline characteristics for individuals with and without the onset of cigarette use and univariate associations with the
onset of daily cigarette use (Continued)
Lower educational level of the mother (Ref) p 2,241 (57.6 %) 157 (59.5 %)
Higher educational level of the mother 1,653 (42.4 %) 107 (40.5 %) 0.92 (0.71–1.19) .541
Financial situation of family (scale 1–7), M (SD) q 3.56 (1.0) 3.6 (1.0) 1.04 (0.92–1.19) .504
Good relationship with parents before age 18, (Ref) r 3,217 (81.4 %) 199 (74.3 %)
Bad relationship with parents before age of 18 733 (81.4 %) 69 (74.3 %) 1.52 (1.14–2.03) .004
Lower parental rule setting at age 15 (Ref) s 1,550 (39.3 %) 121 (45.3 %)
Higher parental rule setting at age 15 2,398 (60.7 %) 145 (54.7 %) 0.78 (0.61–1.001) .051
Lower parental monitoring at age 15 (Ref) t 902 (22.8 %) 74 (27.8 %)
Higher parental monitoring at age 15 3,046 (77.2 %) 192 (72.2 %) 0.77 (0.58–1.02) .063
No psychiatric problem in the father (Ref) u 3,697 (93.9 %) 246 (91.4 %)
Psychiatric problem in the father 241 (6.1 %) 23 (8.6 %) 1.43 (0.92–2.24) .114
No psychiatric problem in the mother (Ref) v 3,783 (96.1 %) 252 (93.7 %)
Psychiatric problem in the mother 154 (3.9 %) 17 (6.3 %) 1.66 (0.99–2.78) .055
No psychiatric problem in peers (Ref) w 2,398 (61.4 %) 116 (43.8 %)
Psychiatric problem in peers 1,507 (38.6 %) 149 (56.2 %) 2.04 (1.59–2.63) <.001
Substance use
Never used≥ 50 cigarettes x 3,169 (80.0 %) 65 (24.2 %) 12.56 (9.40–16.78) <.001
Lifetime use of≥ 50 cigarettes 792 (20.0 %) 204 (75.8 %)
Age of first cigarette smoking, M (SD) y 15.1 (2.4) 14.7 (2.9) 0.94 (0.90–0.99) .026
No use of cigarettes (previous 12 months) (Ref) z 2,774 (70.0 %) 50 (18.6 %)
Occasional (non-daily) cigarette use 1,187 (30.0 %) 219 (81.4 %) 10.24 (7.47–14.02) <.001
No use of tobacco product other than cigarettes (previous 12 months) (Ref) aa 2,189 (55.3 %) 68 (25.3 %)
Use of tobacco product other than cigarettes 1,772 (44.7 %) 201 (74.7 %) 3.65 (2.75–4.84) <.001
Never used≥ 12 alcoholic drinks ab 421 (11.1 %) 13 (4.9 %)
Lifetime use of≥ 12 alcoholic drinks 3,366 (88.9 %) 250 (95.1 %) 2.35 (1.33–4.13) .003
Age of first drink, M (SD) ac 14.6 (1.9) 14.0 (2.03) 0.87 (0.83–0.92) <.001
Alcohol use—no use or not at-risk (AUDIT-C) (previous 12 months) (Ref) ad 1,374 (35.0 %) 58 (21.8 %)
Alcohol use—at-risk 2,550 (65.0 %) 208 (78.2 %) 1.93 (1.43–2.60) <.001
Never used cannabis ae 1,433 (36.2 %) 194 (72.1 %)
Lifetime use of cannabis 2,522 (63.8 %) 75 (27.9 %) 4.55 (3.46–5.99) <.001
Age of first cannabis use, M (SD) af 16.2 (1.8) 15.6 (2.1) 0.84 (0.77–0.90) <.001
No cannabis use (previous 12 months) (Ref) ag 3,125 (18.9 %) 119 (44.2 %)
No problem use (CUDIT) 701 (17.7 %) 95 (35.3 %) 3.56 (2.69–4.72) <.001
Problem use (CUDIT) 134 (3.4 %) 55 (20.4 %) 10.78 (7.50–15.50) <.001
Never used illicit drugs other than cannabis (Ref) ah 3,517 (89.7 %) 181 (68.0 %)
Lifetime use of illicit drugs other than cannabis 406 (10.3 %) 85 (32.0 %) 1.07 (3.08–5.37) <.001
Personality
No attention deficit syndrome (ASRS) (Ref) ai 3,820 (96.6 %) 257 (95.9 %)
Attention deficit syndrome 135 (3.4 %) 11 (4.1 %) 1.21 (0.65–2.27) .550
Sensation seeking (BSSS total score, range 1–5), M (SD) aj 3.0 (0.8) 3.3 (0.9) 1.56 (1.34–1.82) <.001
Aggression (ZKPQ, subscale, range 0–10), M (SD) ak 4.0 (2.2) 4.6 (2.1) 1.13 (1.07–1.20) <.001
Sociability (ZKPQ, subscale, range 0–10), M (SD) al 5.7 (2.3) 6.4 (1.9) 1.15 (1.09–1.22) <.001
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smoking are displayed in Table 1. At baseline, 2,824
(66.8 %) participants reported no cigarette use during
the preceding 12 months, whereas 1,406 (33.2 %) partici-
pants had smoked cigarettes occasionally. Among them,
216 (5.1 %) participants smoked five or six days per
week, 139 (3.3 %) participants smoked three or four days
per week, and 202 (4.8 %) participants smoked two or
three days per month. Furthermore, 240 (5.7 %) partici-
pants had smoked cigarettes two or three days per
month, and 609 (14.4 %) participants smoked monthly
or less often.
Predictors of the onset of daily tobacco use
Between baseline and follow-up, 269 (6.4 %) participants
progressed to daily cigarette smoking. Table 1 shows the
results of the separate logistic regression analyses indi-
cating individual associations between predictors and
the onset of cigarette use. Table 2 presents the category-
specific models and the final model. According to the
final model, having used cannabis and/or having occa-
sionally smoked cigarettes during the 12 months before
baseline, and a lifetime use of more than 50 cigarettes
were associated with a progression to daily cigarette use.
Beyond substance use, the following variables predicted
a higher probability of progression to daily cigarette use:
a lower educational level, having no religious affiliation
(as opposed to Christian religion), having grown up with
only one parent and a step-parent (as opposed to both
parents), having had peers with psychiatric problems,
and a higher sociability. All the variables included in the
final model explain 27.9 % of the variance. The group of
variables related to substance use represented the stron-
gest predictors, with a variance explanation of 25.1 %.
Discussion
This study aimed to examine the role of cannabis use in the
progression of tobacco use, as previously investigated in
several studies dedicated to the reverse gateway hypothesis
[3–5, 47]. Compared to previous studies, we accounted for
a broad range of predictor variables, including variables
that have not been previously studied in this context, e.g.,
religiosity and several personality dimensions. With regard
to the onset of daily cigarette smoking, cannabis use, i.e.,
more pronounced cannabis use disorder symptoms ac-
cording to the CUDIT, remained among the strongest pre-
dictors aside from the lifetime use of more than 50
cigarettes and occasional cigarette use. This strong associ-
ation between cannabis and tobacco use may be partially
explained by the fact that more than 90 % of the Swiss can-
nabis users smoke it mixed with tobacco [15]. Thus, in line
with previous qualitative [10] and quantitative findings [7],
our results suggest that the way of administration of canna-
bis and tobacco, particularly smoking cannabis joints
mixed with tobacco, plays an important role in young
adults’ onset of daily cigarette use, making these findings
particularly relevant for countries in which cannabis is
mainly co-administered with tobacco. Moreover, we found
that the use of tobacco products other than cigarettes (i.e.,
water pipes (shisha, smoked only with tobacco), snus,
snuff, chewing tobacco, cigars/cigarillos, and tobacco pipes)
played a less important role than cannabis use for the onset
of daily cigarette use. This is in line with the study of Agra-
wal and Lynskey [7] in which smoking tobacco was signifi-
cantly associated with cannabis use and dependence
whereas the use of smokeless tobacco was not.
In our study, the factors referring to a genetic vulner-
ability such as a psychiatric disorder of the father/mother
or externalizing and/or delinquent personality traits (anti-
social personality, aggression, sensation seeking, and at-
tention deficit syndrome) did not remain significant in the
overall predictor model. This is in line with the conclusion
of Ramo and colleagues [48] who found in their systematic
literature review that not genetic but environmental fac-
tors appear to account for the largest variance in the co-
use of tobacco and cannabis. Although we did not assess
peers’ substance use and delinquency as an explaining fac-
tor [19], in our models for the onset of daily cigarette
smoking the psychiatric problems of peers at age 15 were
still of higher relevance than genetic factors. Similarly, to
grow up with one parent and step-parent remained as a
further context factor in the overall model. More specific
socio-economic factors or factors indicating a change of
Table 1 Baseline characteristics for individuals with and without the onset of cigarette use and univariate associations with the
onset of daily cigarette use (Continued)
Anxiety (ZKPQ, subscale, range 0–10), M (SD)am 1.9 (1.9) 2.0 (2.0) 1.02 (0.95–1.08) .636
Peer pressure (PPI total score, range −3–+3), M (SD) an 0.3 (0.4) 0.4 (0.4) 1.46 (1.06–2.00) .020
No anti-social personality disorder (Ref) ao 3,429 (87.6 %) 196 (74.5 %)
Anti-social personality disorder 484 (12.4 %) 67 (25.5 %) 2.42 (1.81–3.25) <.001
Separate binary logistic regression model for each baseline variable. Values are n (%) unless stated otherwise. Missing values: an = 1, bn = 74, cn = 28, dn = 31,
en = 30, fn = 134, gn = 62, hn = 63, in = 29, jn = 29, kn = 42, ln = 308, mn = 49, nn = 55, on = 65, pn = 72, qn = 31, rn = 12, sn = 15, tn = 16, un = 23, vn = 24, wn = 60, xn = 0,
yn = 2028, zn = 0, aan = 0, abn = 6, acn = 175, adn = 40, aen = 6, afn = 2,605, agn = 1, ahn = 41, ain = 7, ajn = 3, akn = 5, aln = 5, amn = 5, ann = 81, aon = 54
ASRS Item Screener of the Attention Deficit Syndrome Self Report Scale, AUDIT-C Alcohol Use Disorders Identification Test–Consumption, BSSS Brief Sensation
Seeking Scale, CI confidence interval, CUDIT Cannabis Use Disorder Identification Test, IPAQ International Physical Activity Questionnaire, M mean, MDI Major
Depressive Inventory, OR Odds Ratio, PPI Peer Pressure Inventory, Ref reference category, SD standard deviation, SF-12 Short-Form Health Survey, ZKPQ
Zuckerman-Kuhlman Personality Questionnaire
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Table 2 Multivariate associations between baseline variables and the onset of daily cigarette use
Variable categories and variables Category-specific models Overall model
OR (95 % CI) p OR (95 % CI) p
Socio-demographics
Lower educational level (Ref)
Higher educational level 0.51 (0.37–0.71) <.001 0.45 (0.32–0.65) <.001
Living with parent or parents (Ref)
Living alone 1.45 (0.72–2.92) .294
Living with partner 1.69 (0.84–3.41) .144
Living with friends or in institution 2.25 (1.32–3.84) .003
Religion and spirituality
Christian religion (Ref)
Muslim religion 1.40 (0.71–2.73) .332 1.53 (0.74–3.17) .250
Other religion 1.26 (0.54–2.92) .579 1.01 (0.40–2.56) .982
No religion 1.48 (1.09–2.01) .013 1.42 (1.03–1.97) .035
Atheist (Ref)
Agnostic 0.85 (0.58–1.25) .410
Unsure what to think about god 0.995 (0.66–1.50) .983
Believe in god but not practicing 0.86 (0.61–1.21) .393
Believe in god and practicing 0.49 (0.29–0.84) .010
Health and health behaviour
Depression (MDI, scale 0–50) 1.03 (1.01–1.04) .001
Social context
Grew up with both parents (Ref)
…with parent and step-parent 2.60 (1.71–3.96) <.001 2.16 (1.34–3.49) .002
…with one parent 1.57 (1.12–2.20) .008 1.27 (0.87–1.85) .214
…with adoptive or foster parents or in institution 0.95 (0.29–3.08) .928 0.71 (0.21–2.43) .583
No psychiatric problem in peer/s at age of 15 (Ref)
Psychiatric problem in peer/s at age of 15 1.97 (1.53–2.54) <.001 1.35 (1.02–1.78) .038
Substance use
Never used≥ 50 cigarettes
Lifetime use of≥ 50 cigarettes 4.88 (3.37–7.08) <.001 4.22 (2.89–6.16) <.001
No use of cigarettes during previous 12 months
Occasional (non-daily) cigarette use 3.02 (2.01–4.54) <.001 3.02 (1.99–4.58) <.001
No cannabis use (previous 12 months) (Ref)
No problem use (CUDIT) 1.41 (1.03–1.92) .031 1.52 (1.10–2.09) .011
Problem use (CUDIT) 3.00 (2.02–4.47) <.001 3.06 (2.00–4.67) <.001
Personality
Sensation seeking (BSSS total score, range 1–5), M (SD) 1.36 (1.15–1.60) <.001
Aggression (ZKPQ, subscale, range 0–10) 1.07 (1.01–1.14) .025
Sociability (ZKPQ, subscale, range 0–10) 1.12 (1.06–1.19) <.001 1.12 (1.04–1.20) .002
No anti-social personality disorder (Ref)
Anti-social personality disorder 1.84 (1.33–2.52) <.001
Nagelkerke’s R2: overall model: 0.279, demographics: 0.018, religion and spirituality: 0.012, health and health behaviour: 0.006, social context: 0.032, substance use:
0.251, personality: 0.046
BSSS Brief Sensation Seeking Scale, CI confidence interval, CUDIT Cannabis Use Disorder Identification Test, MDI Major Depressive Inventory, OR Odds Ratio,
Ref reference category, ZKPQ Zuckerman-Kuhlman Personality Questionnaire
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these [21] during adolescence did not enter the overall
model.
Among the religion and spirituality factors, having no
religion was a relevant predictor for the onset of daily
cigarette smoking. Whether substantial gains or losses in
religiosity from childhood to adulthood occurred, a pre-
dictor that has been reported to be associated with sub-
stance use and misuse in the general U.S. population
[20], was not assessed in our study. In line with Agrawal
et al. [11], to believe in God and to practice religion was
the other significant predictor in the category-specific
religion and spirituality model, but this variable did not
enter the overall predictor model.
Considering the amount of variance explained by the
category-specific models, substance abuse explained the
major part of variance (25.1 %) compared to the other
categories (0.6 % to 4.6 %).
One limitation of this study is that the participants
were only observed for a relatively short time period be-
cause they were reassessed at one time point after
15 months. In addition, there was a period of approxi-
mately three months that was not included in the assess-
ments because the follow-up assessment only examined
the preceding 12 months. In order to analyse potential
moderators and mediators in the reverse gateway sce-
nario, cohort studies including multiple assessments
over a longer time period are required. A further limita-
tion is the dichotomized outcome variable (daily cigarette
smoking vs. non-daily cigarette smoking). This implicates
that a group of 216 smokers who smoked cigarettes on 5
to 6 days a week already at baseline were treated as non-
daily smokers and therefore includes in the analysis. These
occasional smokers may have had a particularly high
chance to proceed to daily cigarette smoking and to be
treated as participants with “onset of daily cigarette smok-
ing” which may seem an artificial transition, given they
already smoked already nearly daily at baseline.
Conclusions
According to our findings, appropriate interventions to
prevent young adults from daily cigarette use should
specifically address occasional cigarette smokers and
users of cannabis that mix and smoke these substances
together.
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